Search PDMR transactions

Notifier
Name
Sven Rohmann
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Sven Rohmann
Position
Board member and acting CEO
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
Oasmia Pharmaceutical AB
LEI code
5493003TZPR4B7QO9L49
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
Subscription right Oasmia Pharmaceutical AB - TR SE0013460540 Acquisition 300,000 Quantity 1.453984 SEK 27/11/2019 NASDAQ STOCKHOLM AB
Subscription right Oasmia Pharmaceutical AB - TR SE0013460540 Acquisition 110,528 Quantity 1.622 SEK 27/11/2019 NASDAQ STOCKHOLM AB
Subscription right Oasmia Pharmaceutical AB - TR SE0013460540 Acquisition 400,000 Quantity 1.664332 SEK 27/11/2019 NASDAQ STOCKHOLM AB
Subscription right Oasmia Pharmaceutical AB - TR SE0013460540 Acquisition 89,472 Quantity 1.834047 SEK 27/11/2019 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
Oasmia Pharmaceutical AB - TR SE0013460540 Acquisition 27/11/2019 NASDAQ STOCKHOLM AB 900,000 (Quantity) 1.60588919 SEK
<< Back